Samantha Donnellan

Edinburgh Napier University — United Kingdom

Medicine · Health Sciences

6h-index155citations15works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(6), Cancer therapeutics and mechanisms(5), Mycobacterium research and diagnosis(4), Nanoparticle-Based Drug Delivery(3), Mosquito-borne diseases and control(2)

Publications15 total

Analysing the acute toxicity of e-cigarette liquids and their vapour on human lung epithelial (A549) cells in vitro
Toxicology Reports·2025· 1 citedOpen Access
The potential virulence of Listeria monocytogenes strains isolated from fresh produce processing facilities as determined by an invertebrate Galleria mellonella model
PLoS ONE·2024· 1 citedOpen Access
Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria
All Life·2024· 2 citedOpen Access
A Quantitative Method for the Study of HIV-1 and<i>Mycobacterium tuberculosis</i>Coinfection
The Journal of Infectious Diseases·2022· 4 citedOpen Access
Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
International Journal of Antimicrobial Agents·2022· 23 citedOpen Access
Measurement of the Intracellular Mycobacterium tuberculosis Drug Effect and Prediction of the Clinical Dose–Response Relationship Using Intracellular Pharmacodynamic Modeling (PDi)
Methods in molecular biology·2021
Remdesivir-ivermectin combination displays synergistic interaction with improved <i>in vitro</i> antiviral activity against SARS-CoV-2
2020· 8 citedOpen Access
OA-37-733-24 An in vitro intracellular Mycobacterium tuberculosis and HIV-1 co-infection model suitable for imaging-based platforms
LSTM Online Archive (Liverpool School of Tropical Medicine)·2020
Intracellular Pharmacodynamic Modeling Is Predictive of the Clinical Activity of Fluoroquinolones against Tuberculosis
Antimicrobial Agents and Chemotherapy·2019· 4 citedOpen Access
Nanomedicines towards targeting intracellular <i>Mtb</i> for the treatment of tuberculosis
Journal of Interdisciplinary Nanomedicine·2019· 31 citedOpen Access
Intracellular PD Modelling (PDi) for the Prediction of Clinical Activity of Increased Rifampicin Dosing
Pharmaceutics·2019· 4 citedOpen Access
Intracellular delivery of nano‐formulated antituberculosis drugs enhances bactericidal activity
Journal of Interdisciplinary Nanomedicine·2017· 15 citedOpen Access
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
Scientific Reports·2017· 42 citedOpen Access
Nanomedicines for the treatment of tuberculosis
2016
A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics
Nanotoxicology·2015· 20 citedOpen Access

Frequent Co-authors

Giancarlo A. Biagini(8), Ghaith Aljayyoussi(7), Stephen A. Ward(6), Alison Ardrey(4), Shaun H. Pennington(4), Andrew Owen(3), C. Martínez-Rodríguez(3), Marco Giardiello(2), Laura N. Jeffreys(2), Jack Duggan(2), Claire H Caygill(2), Rose C. Lopeman(2), Alastair F. Breen(2), Jessica Jinks(2), Edward I. Patterson(2), Grant L. Hughes(2), David W. Hong(2), Paul M. O’Neill(2), Lang Tran(2), Helinor J. Johnston(2)